Label Change for Viagra, Cialis, Levitra
The FDA has approved updated labeling for the erectile dysfunction drugs Cialis, Viagra, and Levitra. The change reflects a small number of postmarketing reports of sudden vision loss attributed to NAION (nonarteritic ischemic optic neuropathy) , a condition in which blood flow is blocked to the optic nerve, states an FDA news release.
Tens of millions of men worldwide have used the drugs. The reported vision problems have been extremely rare.
Related posts:
- FDA’s Statement
- Levitra Association with Temporary Amnesia Noted
- Viagra, Cialis, Levitra Information Sheet Warns o f Sudden Hearing Loss
- Viagra and Blindness
- What does Viagra do, exactly?
Comments
Leave a Reply
